Abbott Laboratories Limited v Dexcom Incorporated [2024] EWHC 1664 (Pat)
This patent case is part of the global litigation between the Abbott and Dexcom groups of companies relating to their continuous glucose monitoring devices. This trial (referred to in the UK litigation as ‘Trial B’) concerned the alleged infringement of Abbott’s patent EP 3,730,044 by Dexcom’s ‘G7’ CGM device. The patent was held invalid and not infringed.
Iain Purvis KC and Christopher Hall acted for Dexcom.